The average P/S ratio for ITOS's competitors is 19.16, providing a benchmark for relative valuation. Iteos Therapeutics Inc Corp (ITOS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.